MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 7 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q3 2026, worth $14.2M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in MAIA Biotechnology, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +7 vs. Q2 2026
- Shares held
- 12.2M
- −1.37M (−10.1%) vs. Q2 2026
- Total value
- $14.2M
- −$5.19M (−26.7%) vs. Q2 2026
- New holders
- 9
- 6 more added
- Sold out
- 2
- 10 more reduced
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 43 | $14.2M |
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Solas Capital Management, LLC | 3,030,845 | $3.58M | 2.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,413,270 | $2.85M | 0.00% | 00.0% | Unchanged |
| Centric Wealth Management | 1,167,070 | $1.27M | 0.19% | +370,347+46.5% | Added |
| 683 Capital Management, LLC | 1,066,666 | $1.26M | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 584,401 | $689.8K | 0.00% | +80,021+15.9% | Added |
| Cable Car Capital LLC | 514,583 | $607.2K | 0.18% | 00.0% | Unchanged |
| Bleichroeder LP | 500,000 | $590.0K | 0.06% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 399,100 | $470.9K | 0.00% | −16,600−4.0% | Reduced |
| BlackRock, Inc. | 394,772 | $465.8K | 0.00% | −8,239−2.0% | Reduced |
| Vanguard Fiduciary Trust Co | 336,688 | $397.3K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 295,436 | $348.6K | 0.00% | −2,204,564−88.2% | Reduced |
| Citadel Advisors LLC | 226,877 | $267.7K | 0.00% | +201,987+811.5% | Added |
| State Street Corp | 218,850 | $258.2K | 0.00% | +17,100+8.5% | Added |
| Bleakley Financial Group, LLC | 181,623 | $214.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 125,171 | $147.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 104,017 | $122.7K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 84,774 | $100.0K | 0.00% | +84,774 | New |
| Bridgeway Capital Management, LLC | 74,757 | $88.2K | 0.00% | −1,243−1.6% | Reduced |
| Empowered Funds, LLC | 74,757 | $88.2K | 0.00% | +74,757 | New |
| StoneX Group Inc. | 60,151 | $77.7K | 0.00% | +60,151 | New |
| Envestnet Asset Management Inc | 40,150 | $47.4K | 0.00% | −4,197−9.5% | Reduced |
| Quadrature Capital Ltd | 37,840 | $44.7K | 0.00% | +37,840 | New |
| PVG Asset Management Corp | 34,135 | $40.3K | 0.03% | 00.0% | Unchanged |
| Spark Investment Management LLC | 25,400 | $30.0K | 0.05% | +25,400 | New |
| Lazari Capital Management, Inc. | 21,750 | $25.7K | 0.01% | 00.0% | Unchanged |
| Atria Investments LLC | 20,754 | $24.5K | 0.00% | −346−1.6% | Reduced |
| Cetera Investment Advisers | 18,669 | $22.0K | 0.00% | −4,079−17.9% | Reduced |
| Point72 Asset Management, L.P. | 17,175 | $20.3K | 0.00% | +17,175 | New |
| Centerpoint Advisory Group | 15,730 | $18.6K | 0.01% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 14,800 | $17.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,917 | $16.4K | 0.00% | −36,466−72.4% | Reduced |
| Vanguard Global Advisers, LLC | 11,401 | $13.5K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,334 | $9.83K | 0.00% | 00.0% | Unchanged |
| Daytona Street Capital LLC | 7,500 | $8.93K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,312 | $6.27K | 0.00% | +2,104+65.6% | Added |
| Nuveen, LLC | 2,357 | $2.71K | 0.00% | +2,357 | New |
| Citigroup Inc | 1,831 | $2.16K | 0.00% | +1,681+1,120.7% | Added |
| Strategic Investment Solutions, Inc. | 300 | $354 | 0.00% | +300 | New |
| Jones Financial Companies LLLP | 228 | $274 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 200 | $236 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 177 | $209 | 0.00% | −33−15.7% | Reduced |
| JPMorgan Chase & Co | 23 | $26 | 0.00% | +23 | New |
| Barclays PLC | 3 | $4 | 0.00% | −4,149−99.9% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −35,223−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −33,435−100.0% | Sold out |